Open AccessImpact of National Ten-Valent Pneumococcal Conjugate Vaccine Program on Reducing Antimicrobial Use and Tympanostomy Tube Placements in Finland
Author(s) -
Arto A. Palmu,
Hanna Rinta-Kokko,
Hanohynek,
J. Pekka Nuorti,
Jukka Jokinen
Publication year - 2018
Publication title -
the pediatric infectious disease journal/the pediatric infectious disease journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.028
H-Index - 140
eISSN - 1532-0987
pISSN - 0891-3668
DOI - 10.1097/inf.0000000000001810
Subject(s) - pneumococcal conjugate vaccine , tympanostomy tube , medicine , antimicrobial , conjugate , pediatrics , streptococcus pneumoniae , surgery , microbiology and biotechnology , antibiotics , biology , mathematics , mathematical analysis , otitis
Otitis media in young children is associated with major resource use including antimicrobial consumption and tympanostomy tube placements (TTPs). We evaluated the impact of 10-valent pneumococcal conjugate vaccine (PCV10) introduction into the Finnish National Vaccination Programme (NVP) against these outcomes in vaccine-eligible children.